Q4 2024 Holdings
Filed 2025-02-14 | 7 holdings | $170.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Pharvaris N V(PHVS) | COM | N69605108 | $82.2M | 4,289,304 | 48.2% |
| Alumis Inc(ALMS) | COM | 022307102 | $21.9M | 2,787,398 | 12.8% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $18.6M | 539,194 | 10.9% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $16.2M | 9,699,925 | 9.5% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $15.3M | 1,519,971 | 9.0% |
| Acelyrin Inc | COM | 00445A100 | $12.0M | 3,806,410 | 7.0% |
| Lyell Immunopharma Inc | COM | 55083R104 | $4.5M | 7,102,190 | 2.7% |